
Remedent, Inc. – OTC:REMI
Remedent stock price today
Remedent stock price yearly change
Remedent key metrics
Market Cap | 3.39M |
Enterprise value | 3.32M |
P/E | -8.5 |
EV/Sales | 2.94 |
EV/EBITDA | -16.25 |
Price/Sales | 3.01 |
Price/Book | 0.74 |
PEG ratio | 0.06 |
EPS | -0.05 |
Revenue | 962.57K |
EBITDA | -701.69K |
Income | -1.17M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -22.98% |
Oper. margin | -9.45% |
Gross margin | 65.38% |
EBIT margin | -9.45% |
EBITDA margin | -72.9% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeRemedent stock price history
Remedent stock forecast
Remedent financial statements
Sep 2019 | 242.07K | -159.59K | -65.93% |
---|---|---|---|
Dec 2019 | 262.07K | -163.28K | -62.3% |
Mar 2020 | 250.30K | -355.93K | -142.2% |
Mar 2023 | 208.12K | -498.49K | -239.52% |
Jun 2022 | 6512982 | 2.60M | 40.03% |
---|---|---|---|
Sep 2022 | 6113105 | 2.52M | 41.34% |
Dec 2022 | 5940787 | 2.67M | 44.97% |
Mar 2023 | 5588416 | 2.85M | 51.06% |
Jun 2020 | 20.84K | 0 | 0 |
---|---|---|---|
Sep 2020 | 94.76K | 0 | 0 |
Dec 2020 | 68.49K | 0 | 0 |
Mar 2023 | 65.75K | 0 | 0 |
Remedent alternative data
Aug 2023 | 3 |
---|---|
Sep 2023 | 3 |
Oct 2023 | 3 |
Nov 2023 | 3 |
Dec 2023 | 3 |
Jan 2024 | 3 |
Feb 2024 | 3 |
Mar 2024 | 3 |
Apr 2024 | 3 |
May 2024 | 3 |
Jun 2024 | 3 |
Jul 2024 | 3 |
Remedent other data
-
What's the price of Remedent stock today?
One share of Remedent stock can currently be purchased for approximately $0.01.
-
When is Remedent's next earnings date?
Unfortunately, Remedent's (REMI) next earnings date is currently unknown.
-
Does Remedent pay dividends?
No, Remedent does not pay dividends.
-
How much money does Remedent make?
Remedent has a market capitalization of 3.39M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 14.17% to 986.22K US dollars.
-
What is Remedent's stock symbol?
Remedent, Inc. is traded on the OTC under the ticker symbol "REMI".
-
What is Remedent's primary industry?
Company operates in the Healthcare sector and Medical Instruments & Supplies industry.
-
How do i buy shares of Remedent?
Shares of Remedent can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Remedent have?
As Jul 2024, Remedent employs 3 workers.
-
When Remedent went public?
Remedent, Inc. is publicly traded company for more then 18 years since IPO on 4 Dec 2006.
-
What is Remedent's official website?
The official website for Remedent is remedent.com.
-
How can i contact Remedent?
Remedent can be reached via phone at +32 9 241 58 80.
Remedent company profile:

Remedent, Inc.
remedent.comOTC
3
Medical Instruments & Supplies
Healthcare
Remedent, Inc., through its subsidiaries, researches, designs, develops, manufactures, and distributes oral care and cosmetic dentistry products. It primarily provides professional veneers and teeth whitening products for professional and over-the-counter use. The company offers River8, a prefab veneer that enables the dentist to find the right combination of teeth for a patient with minor reshaping. It also provides GlamSmile veneers, which are ultra-thin claddings attached to the front of the patient's teeth. In addition, the company offers SmileMe Mirror, an integrated marketing concept for the dental practice, which enables dentists to offer smile consultation in approximately 10 minutes; SmileSketch, a simulation software to make a sketch of what the patient could look like; and various Treatment Pages to explain the benefits of certain treatments, as well as Condor, an intra-oral 3D scanner. Further, it provides dental implant solutions and treatment concepts. The company sells its products to dental professionals in approximately 30 countries, including Asia, Europe, the Middle East, Canada, and the United States through its internal sales force and third party distributors. The company was founded in 1986 and is headquartered in Ghent, Belgium.
Gent, 9000
CIK: 0001078037
ISIN: US75954T1043
CUSIP: 75954T104